News

A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.

Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.

2015 developments reflect another positive year of growth for the pharmaceutical service provider.

An oral oxytocin receptor antagonist for the treatment of premature ejaculation.

AbCellera’s single cell antibody discovery technology unlocks the power of natural immunity.

Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market.

World leading pioneer on drug discovery through open innovation, joins the stem cell disease model specialists.

Obesity can sometimes be shut down.

A team of international researchers including scientists from Oxford University has found that HIV is still replicating in lymphoid tissue even when it is undetectable in the blood of patients on antiretroviral drugs.

Startup develops more cost-effective test for assessing how cells respond to chemicals.